Causes of early-onset type 1 diabetes: Toward data-driven environmental approaches

Journal of Experimental Medicine

Volumn 205, Issue 13, 2008, Pages 2953-2957

  Bougnères, Pierre ^a   Valleron, Alain Jacques ^b  

^a INSERM   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; CAUSAL ATTRIBUTION; CELL DESTRUCTION; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; ENVIRONMENT; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; METABOLOMICS; PATHOLOGY; PATHOPHYSIOLOGY;

AUTOANTIBODY; GLUTAMIC ACID;

AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GLUTAMIC ACID; HUMANS; INSULIN-SECRETING CELLS; METABOLOMICS;

EID: 59649086890     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20082622     Document Type: Note

References (34)

1. Bottazzo, G.F., A. Florin-Christensen, and D. Doniach. 1974. Islet-cell antibodies in diabetes mellitus with autoimmune polyen-docrine deficiencies. Lancet. ii: 1280-1283.
2. Nerup, J., P. Platz, O.O. Andersen, M. Christy, J. Lyngsoe, J.E. Poulsen, L.P. Ryder, L.S. Nielsen, M. Thomsen, and A. Svejgaard. 1974. HL-A antigens and diabetes mellitus. Lancet. ii:864-866.
3. Benacerraf, B., and H.O. McDevitt. 1972. Histocompatibility-linked immune response genes. Science. 175:273-279.
4. Srikanta, S., O.P. Ganda, G.S. Eisenbarth, and J.S. Soeldner. 1983. I slet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetesmellitus. N. Engl. J. Med. 308:322-325.
5. Ziegler, A.G., M. Hummel, M. Schenker, and E. Bonifacio. 1999. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes. 48:460-468.
6. Orešič, M., S. Simell, M. Sysi-Aho, K. Näntö- Salonen, T. Seppanen-Laakso, V. Parikka, M. Katajamaa, A. Hekkala, I. Mattila, P. Keskinen, et al. 2008. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J. Exp. Med. 205:2975-2984.
7. Hack, V., O. Stutz, R. Kinscherf, M Schykowski, M. Kellerer, E. Holm, and W. Droge. 1996. Elevated venous glutamate levels in (pre)catabolic conditions result at least partly from a decreased glutamate transport activity. J. Mol. Med. 74:337-343.
8. Darmaun, D., D. Matthews, and D.M. Bier. 1986. Glutamine and glutamate kinetics in humans. Am. J. Physiol. Endocrinol. Metab. 251: E117-E126.
9. Mourtzakis, M., and T.E. Graham. 2002. Glutamate ingestion and its effects at rest and during exercise in humans. J. Appl. Physiol. 93: 1251-1259.
10. Beyreuther, K., H.K. Biesalski, J.D. Fernstrom, P. Grimm, W.P. Hammes, U. Heinemann, O. Kempski, P. Stehle, H. Steinhart, and R. Walker. 2007. Consensus meeting: monosodium glutamate, an update. Eur. J. Clin. Nutr. 61:304-313.
11. Kelly, A., C. Li, Z. Gao, C.A. Stanley, and F.M. Matchinsky. 2002. Glutaminolysis and insulin secretion. Diabetes. 51:S421-S426.
12. Teng, W., Z. Shan, X. Teng, H. Guan, Y. Li, D. Teng, Y. Jin, X. Yu, C. Fan, W. Chong, et al. 2006. Effect of iodine intake on thyroid diseases in China? N. Engl. J. Med. 354:2783-2793.
13. Moreau, P.L. 2007. The lysine decarboxyl-ase CadA protects Escherichia coli starved of phosphate against fermentation acids. J. Bacteriol. 189:2249-2261.
14. Newsholme, P. 2001. Why is glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection. J. Nutr. 131:2515S-2522S.
15. Murugesan, G., M.R. Sandhya Rani, C.E. Gerber, C. Mukhopadhyay, R.M. Ransohoff G.M. Chisolm, and K.J. Kottke-Marchant. 2003. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines. J. Mol Cell. Cardiol. 35: 1375--1384.
16. Bao, S., H. Song, M. Wohltmann, S. Ramanadham, W. Jin, A. Bohrer, and J. Turk. 2006. Insulin secretory responses and phospho-lipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis. J. Biol. Chem. 281:20958-20973.
17. Green, A., and C.C. Patterson. 2001. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia. 44:B3-B8.
18. Strachan, D.P. 1989. Hay fever, hygiene, and household size. BMJ. 299:1259-1260.
19. Bach, J.F. 2002. The effects of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347:911-920.
20. Flahault, A., T. Blanchon, Y. Dorléans, L. Toubiana, J.F. Vibert, and A.J. Valleron. 2006. Virtual surveillance of communicable diseases: a 20-year experience in France. Stat. Methods Med. Res. 15:413-421.
21. Eckburg, P.B., E.M. Bik, C.N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S.R. Gill, K.E. Nelson, and D.A. Relman. 2005. Diversity of the human intestinal microbial flora. Science. 308:1635-1638.
22. Bjornsson, H.T., M.D. Fallin, and A.P. Feinberg. 2004. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 20:350-358.
23. Gill, S.R., M. Pop, R.T. Deboy, P.B. Eckburg, P.J. Turnbaugh, B.S. Samuel, J .I. Gordon, D.A. Relman, C.M. Fraser-Liggett, and K. Nelson. 2006. Metagenomic analysis of the human distal gut microbiome. Science. 312:1355-1359.
24. Holmes, E., I.D. Wilson, and J.K. Nicholson. 2008. Metabolic phenotyping in health and disease. Cell. 134:714-717.
25. Christakis, N.A., and J.H. Fowler. 2007. The- spread of obesity in a large social network over 32 years. N. Engl. J. Med. 357:370-379.
26. Turnbaugh, P.J., and J.I. Gordon. 2008. An invitation to the marriage of metagenomics and metabolomics. Cell. 134:708-713.
27. Van den Veyver, I.B. 2002. Genetic effects of methylation diets. Annu. Rev. Nutr. 22: 255-282.
28. Hugot, J.P., C. Alberti, D. Berrebi, E. Bingen, and J .P. Cezard. 2003. Crohn's disease: the cold chain hypothesis. Lancet. 362:2012-2015.
29. Gillespie, K.M., S.C. Bain, A.H. Barnett, P.J. Bingley, M.R. Christie, G.V. Gill, and E.A.Gale. 2004. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet. 364:1699-1700.
30. Ebrahim, S., and G. Davey Smith. 2008. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum. Genet. 123:15-33.
31. Kukko, M., S.M. Virtanen, A. Toivonen, S. Simell, S. Korhonen, J. Ilonen, O. Simel, and M. Knip. 2004. Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell autoimmunity in a high-incidence country. Diabetes Care. 27:676-681.
32. Idaghdour, Y., J.D. Storey, S.J. Jadallah, and G. Gibson. 2008. A genome-wide gene expression signature of environmental geography in leukocytes of Moroccan Amazighs. PLoS Genet. 4:e1000052.
33. Schadt, E.E., C. Molony, E. Chudin, K. Hao, X. Yang, P.Y. Lum, A. Kasarskis, B. Zhang, S. Wang, C. Suver, et al . 2008. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6:e107.
34. Moffatt, M.F., M. Kabesch, L. Liang, A.L. Dixon, D. Strachan, S. Heath, M. Depner, A. von Berg. A. Bufe, E. Rietschel, et al . 2007. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature. 448:470-473.